Acute Intermittent PorphyriaSymptoms, Doctors, Treatments, Advances & More
Acute Intermittent Porphyria Overview
Learn About Acute Intermittent Porphyria
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Karolinska Institutet
Eliane Sardh practices practicing medicine in Stockholm, Sweden. Ms. Sardh is rated as an Elite expert by MediFind in the treatment of Acute Intermittent Porphyria. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Acute Intermittent Porphyria, Acute Hepatic Porphyria (AHP), Porphyria, and Variegate Porphyria.
Karolinska Institutet
Pauline Harper practices practicing medicine in Stockholm, Sweden. Ms. Harper is rated as an Elite expert by MediFind in the treatment of Acute Intermittent Porphyria. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Acute Intermittent Porphyria, Porphyria, Acute Hepatic Porphyria (AHP), and Variegate Porphyria.
Ulrich Stolzel practices practicing medicine in Chemnitz, Germany. Mr. Stolzel is rated as an Elite expert by MediFind in the treatment of Acute Intermittent Porphyria. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Hepatic Porphyria (AHP), Porphyria, Acute Intermittent Porphyria, Hereditary Coproporphyria, and Liver Transplant.
Summary: The main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria). Aim: Investigate the diet's impact on tissue and serum glucose, plasma insulin, cytokine levels, amino acids, and gut microbiota in AIP, and their correlation with PBG (Porphobilinogen). Aim: Assess the diet's effect on AIP symptoms and health status in ...
Summary: The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.